Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Intangibles (2021)

Kiniksa Pharmaceuticals International (KNSA) has disclosed Change in Intangibles for 1 consecutive years, with $20.0 million as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Change in Intangibles changed N/A year-over-year to $20.0 million, compared with a TTM value of $20.0 million through Dec 2021, changed N/A, and an annual FY2021 reading of $20.0 million, changed N/A over the prior year.
  • Change in Intangibles was $20.0 million for Q1 2021 at Kiniksa Pharmaceuticals International.
  • Across five years, Change in Intangibles topped out at $20.0 million in Q1 2021 and bottomed at $20.0 million in Q1 2021.